Based on our internationally recognized expertise in diabetes, obesity, pancreatic ß-cell function, and brain, we offer a complete array of preclinical services for compound testing and target validation using state-of-the-art approaches and experimental models.
Betagenex
Betagenex is a preclinical Contract Research Organization (CRO) providing scientific expertise and drug discovery services in metabolic diseases to the pharmaceutical and biotech industries.
Research Capabilities
Platform
- Assessment of ß-cell function
- Metabolic phenotyping
- Targeted animal models
Innovation and new products
05.19.2011
Betagenex: the beta-cell function experts providing customized drug development services to the biopharmaceutical industry
Vincent Poitout, DVM, PhD, Thierry Sulpice, PhD, Marc Prentki, PhD, Rémy Burcelin, PhD and Thierry Alquier, PhD are pleased to announce the launch of Betagenex, a preclinical Contract Research Organization (CRO) providing scientific expertise and drug discovery services in metabolic diseases to the pharmaceutical and biotech industries.
News
03.29.2012
The Cardiometabolic hub is launched!
The cardiometabolic hub is a consortium of highly specialized contract research organizations that pool their scientific expertises, preclinical and clinical skills and technical resources to provide outstanding research services and consulting for pharmaceutical, biotechnology and nutraceutical companies worldwide.
+
All news